Haemagglutinin and nucleoprotein replicon particle vaccination of swine protects against the pandemic H1N1 2009 virus

Veterinary Record

Volumn 173, Issue 14, 2013, Pages 344-

  Vander Veen, R L ^a,b   Mogler, M A ^a   Russell, B J ^d   Loynachan, A T ^e   Harris, D L H ^a,d   Kamrud, K I ^a,c  

^a Harrisvaccines Inc   (United States)

^b ZOETIS   (United States)

^c Synthetic Genomics Inc   (United States)

^d IOWA STATE UNIVERSITY   (United States)

^e UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ; INFLUENZA VACCINE; NUCLEOPROTEIN; VACCINE;

ALPHA VIRUS; ANIMAL; ARTICLE; GENETICS; HUMAN; IMMUNOLOGY; INFLUENZA; INFLUENZA VIRUS A H1N1; PANDEMIC; REPLICON; REPLICON PARTICLE; SWINE; TREATMENT OUTCOME;

ALPHAVIRUS; IMMUNOLOGY; INFLUENZA; REPLICON PARTICLE; VACCINES;

ANIMALS; HEMAGGLUTININS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; NUCLEOPROTEINS; PANDEMICS; REPLICON; SWINE; TREATMENT OUTCOME;

EID: 84885597837     PISSN: 00424900     EISSN: None     Source Type: Journal    
DOI: 10.1136/vr.101741     Document Type: Article

References (43)

1. BENDER, B. S., BELL, W. E., TAYLER, S., SMALL JR, P. A. (1994) Class I major histocompatability complex-restricted cytotoxic T lymphocytes are not necessary for heterosubtypic immunity to influenza. The Journal of Infectious Diseases 170, 1195-1200 (Pubitemid 24328623)
2. BOSWORTH, B., ERDMAN, M. M., STINE, D. L., HARRIS, I., IRWIN, C., JENS, M., LOYNACHAN, A., KAMRUD, K., HARRIS, D.L. (2010) Replicon particle vaccine protects swine against influenza. Comparative Immunology, Microbiology 33, 99-103
3. CARRAGHER, D. M., KAMINSKI, D. A., MOQUIN, A., HARTSON, L., RANDALL, T. D. (2008) A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus. Journal of Immunology 181, 4168-4176
4. CENTERS FOR DISEASE CONTROL AND PREVENTION (2012) Evaluation of rapid influenza diagnostic tests for influenza A (H3N2) v virus and update case count-United States, 2012. Morbidity and Mortality Weekly Report 61, 619-621
5. DUCATEZ, M. F., HAUSE, B., STIGGER-ROSSER, E., DARNELL, D., CORZO, C., JULEEN, K., SIMONSON, R., BROCKWELL-STAATS, C., RUBRUM, A., Wang, D., Web, A., Crumpton, J. C., Lowe, J., Gramer, M., Weby, R., J. (2011) Multiple reassortment between pandemic (H1N1) 2009 and endemic influenza viruses in pigs, United States. Emerging Infectious Diseases 17, 1624-1629
6. EPSTEIN, S. L., LO, C.-Y., MISPLON, J. A., LAWSON, C. M., HENDRICKSON, B. A., MAX, E. E., SUBBARAO, K. (1997) Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in fully immunocompetent, T cell-depleted, B2-microglobulin defiecient, and J chain-deficient mice. Journal of Immunology 158, 1222-1230 (Pubitemid 127469945)
7. ERDMAN, M. M., KAMRUD, K. I., HARRIS, D. L., SMITH, J. (2010) Alphavirus vector vaccines developed for use in humans induce high levels of antibodies to influenza virus hemagglutinin in swine: proof of concept. Vaccine 28, 594-596
8. GARTEN, R. J., DAVIS, C. T., RUSSELL, C. A., SHU, B., LINDSTROM, S., BALISH, A., SESSIONS, W. M., XU, X., SKEPNER, E., DEYDE, V., OKOMO-ADHIAMBO, M., GUBAREVA, L., BARNES, J., SMITH, C. B., EMERY, S. L., HILLMAN, M. J., RIVAILLER, P., SMAGALA, J., DE GRAAF, M., BURKE, D. F., FOUCHIER, R. A. M., PAPPAS, C., ALPUCHE-ARANDA, C. M., LOPEZ-GATELL, H., OLIVERA, H., LOPEZ, I., MYERS, C. A., FAIX, D., BLAIR, P. J., YU, C., KEENE, K. M., DOTSON, P. D., BOXRUD, D., SAMBOL, A. R., ABID, S. H., ST GEORGE, K., BANNERMAN, T., MOORE, A. L., STRINGER, D. J., BLEVINS, P., DEMMLERHARRISON, G. J., GINSBERG, M., KRINER, P., WATERMAN, S., SMOLE, S., GUEVARA, H. F., BELONGIA, E. A., CLARK, P. A., BEATRICE, S. T., DONIS, R., KATZ, J., FINELLI, L., BRIDGES, C. B., SHAW, M., JERNIGAN, D. B., UYEKI, T. M., SMITH, D. J., KLIMOV, A. I., COX, N. J. (2009) Antigenic and genetic characteristics of swine-origin 2009 A (H1N1) influenza viruses circulating in humans. Science 325, 197-201
9. GAUGER, P. C., VINCENT, A. L., LOVING, C. L., LAGER, K. M., JANKE, B. H., KEHRLI JR, M. E., ROTH, J. A. (2011) Enhanced pneumonia and disease in pigs vaccinated with an inactivated human-like (delta-cluster) H1N2 vaccine and challenged with pandemic 2009 H1N1 influenza virus. Vaccine 29, 2712-2719
10. GERHARD, W., MOZDZANOWSKA, G., FURCHNER, M., WASHKO, G., MAIESE, K. (1997) Role of the B-cell response in recovery of mice from primary influenza infection. Immunological Reviews 159, 95-103 (Pubitemid 27499862)
11. HALBUR, P. G., PAUL, P. S., FRAY, M. L., LANDGRAF, J., EERNISSE, K., MENG, X. J., LUM, M. A., ANDREWS, J. J., RATHJE, J. A. (1995) Comparison of the pathogenicity of two US porcine reproductive and respiratory syndrome virus Isolates with that of the Lelystad virus. Veterinary Pathology 32, 648-660
12. HEINEN, P. P., RIJSEWIJK, F. A., DE BOER-LUIJTZE, E. A., BIANCHI, A. T. J. (2002) Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus. The Journal of General Virology 83, 1851-1859 (Pubitemid 34846448)
13. HUBBY, B., TALARICO, T., MAUGHAN, M., REAP, E. A., BERGLUND, P., KAMRUD, K. I., COPP, L., LEWIS, W., CECIL, C., NORBERG, P., WAGNER, J., WATSON, A., NEGRI, S., BURNETT, B. K., GRAHAM, A., SMITH, J. F., CHULAY, J. D. (2007) Development and preclinical evalution of an alphavirus replicon vaccine for influenza. Vaccine 25, 8180-8189 (Pubitemid 350046318)
14. KAMRUD, K. I., CUSTER, M., DUDEK, J. M., OWENS, G., ALTERSON, K. D., LEE, J. S., GROEBNER, J. L., SMITH, J. F. (2007) Alphavirus replicon approach to promoterless analysis of IRES elements. Virology 360, 376-387 (Pubitemid 46486674)
15. MALDONADO, J., VAN REETH, K., RIERA, P., SITJA, M., SAUBI, N., ESPUNA, E., ARTIGAS, C. (2006) Evidence of the concurrent circulation of H1N2, H1N1 and H3N2 influenza A viruses in densely populated areas in Spain. Veterinary Journal 172, 377-381 (Pubitemid 44159267)
16. MASTIN, A., ALARCON, P., PFEIFFER, D., WOOD, J., WILLIAMSON, S., BROWN, I., WIELAND, B., COSI CONSORTIUM. (2011) Prevalence and risk factors for swine influenza virus infection in the English pig population. PLoS Currents 3, RRN1209
17. MYERS, K. P., OLSEN, C. W., GRAY, G. C. (2010) Cases of swine influenza in humans: a review of the literature. Clinical Infectious Diseases: an Official Publication of the Infectious Diseases Society of America 44, 1084-1088 (Pubitemid 46580277)
18. RANGEL-MORENO, J., CARRAGHER, D. M., MISRA, R. S., KUSSER, K., HARTSON, L., MOQUIN, A., LUND, F. E., RANDALL, T.D. (2008) B cells promote resistance to heterosubtypic strains of influenza via multiple mechanisms. Journal of Immunology 180, 454-463
19. RAYNER, J. O., DRYGA, S. A., KAMRUD, K. I. (2002) Alphavirus vectors and vaccination. Reviews in Medical Virology 12, 279-296
20. REED, L. J., MUENCH, H. (1938) A simple method of estimating fifty percent endpoint. American Journal of Hygiene 27, 493-497
21. RICHT, J. A., LAGER, K. M., JANKE, B. H., WOODS, R. D., WEBSTER, R. G., WEBBY, R. J. (2003) Pathogenic and antigenic properties of phylogenetically distinct reassortant H3N2 swine influenza viruses cocirculating in the United States. Journal of Clinical Microbiology 41, 3198-3205 (Pubitemid 36842322)
22. SCHULTZ-CHERRY, S., DYBING, J. K., DAVIS, N. L., WILLIAMSON, C., SUAREZ, D. L., JOHNSTON, R., PERDUE, M. L. (2000) Influenza virus (A/HK/156/97) hemagglutinin expressed by an alphavirus replicon system protects chickens against lethal infection with Hong Kong-origin H5N1 viruses. Virology 278, 55-59 (Pubitemid 32002594)
23. SHINDE, V., BRIDGES, C. B., UYEKI, T. M., SHU, B., BALISH, A., XU, X., LINDSTROM, S., GUBAREVA, L. V., DEYDE, V., GARTEN, R. J., HARRIS, M., GERBER, S., VAGASKY, S., SMITH, F., PASCOE, N., MARTIN, K., DUFFICY, D., RITGER, K., CONOVER, C., QUINLISK, P., KLIMOV, A., BRESEE, J. S., FINELLI, L. (2009) Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. The New England Journal of Medicine 361, 2616-2625
24. TO, K. F. W., ZHANG, A. J. X., HUNG, I. F. N., XU, T., IP, W. C. T., WONG, R. T. Y., NG, J. C. K., CHAN, J. F. W., CHAN, K. H., YUEN, K. Y. (2012) High titer and avidity of nonneutralizing antibodies against influenza vaccine antigen are associated with severe influenza. Clinical and Vaccine Immunology: CVI 19, 1012-1018
25. TOPHAM, D. J., DOHERTY, P. C. (1998) Clearance of an influenza A virus by CD4+ T cells is inefficient in the abscence of B cells. Journal of Virology 72, 882-885 (Pubitemid 28048918)
26. TREMBLAY, D., ALLARD, V., DOYON, J. F., BELLEHUMEUR, C., SPEARMAN, J. G., HAREL, J., GAGNON, C. A. (2011) Emergence of a new swine H3N2 and pandemic (H1N1) 2009 influenza A virus reassortant in two Canadian animal populations, mink and swine. Journal of Clinical Microbiology 49, 4386-4390
27. ULMER, J. B., DONNELLY, J. J., PARKER, S. E., RHODES, G. H., FELGNER, P. L., DWARKI, V. J., Gromkowski, S. H., Deck, R. R., DeWit, C. M., Friedman, A., Hawe, L. A., Leander, K. R., D., Pery, H. C., Shiver, J. W., Montgomery, D. L., Liu, M.A. (1993) Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259, 1745-1749 (Pubitemid 23114660)
28. ULMER, J. B., FU, T. M., DECK, R. R., FRIEDMAN, A., GUAN, L., DEWITT, C., LIU, X., WANG, S., LIU, M. A., DONNELLY, J. J., CAULFIELD, M. J. (1998) Protective CD4+ and CD8+ T Cells against influenza virus induced by vaccination with nucleoprotein DNA. Journal of Virology 72, 5648-5653 (Pubitemid 28283349)
29. VANDER VEEN, R., KAMRUD, K., MOGLER, M., LOYNACHAN, A., MCVICKER, J., OWENS, G., BERGLUND, P., TIMBERLAKE, S., WHITNEY, L., SMITH, J., HARRIS, D. (2009) Rapid development of an efficacious wwine vaccine for novel H1N1. PLoS Currents: Influenza 1, RRN1123
30. VANDER VEEN, R. L., HARRIS, D. L., KAMRUD, K. I. (2012a) Alphavirus replicon vaccines. Animal Health Research Reviews/Conference of Research Workers in Animal Diseases 13, 1-9
31. VANDER VEEN, R. L., LOYNACHAN, A. T., MOGLER, M. A., RUSSELL, B. J., HARRIS, D. L., KAMRUD, K. I. (2012b) Safety, immunogenicity, and efficacy of an alphavirus replicon-based influenza virus hemagglutinin vaccine. Vaccine 30, 1944-1950
32. VAN REETH, K., BROWN, I., DURRWALD, R., FONI, E., LABARQUE, G., LENIHAN, P., MALDONADO, J., MARKOWSKA-DANIEL, I., PENSAERT, M. POSPISIL, Z., KOCH, G. (2008) Seroprevalence of H1N1, H3N2, and H1N2 influenza viruses in pigs in seven European coountries in 2002-2003. Influenza and Other Respiratory Viruses 2, 99-105
33. VELDERS, M. P., MCELHINEY, S., CASSETTI, M. C., EIBEN, G. L., HIGGINS, T., KOVACS, G. R., ELMISHAD, A. G., KAST, W. M., SMITH, L. R. (2001) Eradication of established tumors by vaccination with Venezuelan equine encephalitis virus replicon particles delivering human papillomavirus 16E7 RNA. Cancer Research 61, 7861-7867 (Pubitemid 33049376)
34. VINCENT, A., MA, W., LAGER, K. M., GRAMER, M. R., JANKE, B. H., RICHT, J. A. (2008a) Swine influenza viruses: a North American perspective. Advances in Virus Research 72, 127-154
35. VINCENT, A., SWENSON, S., LAGER, K., GAUGER, P., LOIACONO, C., ZHANG, Y. (2009) Characterization of an influenza A virus isolated from pigs during an outbreak of respiratory disease in swine and people during a county fair in the United States. Veterinary Microbiology 137, 51-59
36. VINCENT, A. L., CIACCI-ZANELLA, J. R., LORUSSO, A., GAUGER, P. C., ZANELLA, E. L., KEHRLI JR, M. E., JANKE, B. H., LAGER, K. M. (2010a) Efficacy of inactivated swine influenza virus vaccines against the 2009 A/H1N1 influenza virus in pigs. Vaccine 28, 2782-2787
37. VINCENT, A. L., LAGER, K. M., FAABERG, K. S., HARLAND, M., ZANELLA, E. L., CIACCIE-ZANELLA, J. R., KEHRLI, M. E. JR, HANKE, B. H., KLIMOV, A. (2010b) Experimental inoculation of pigs with pandemic H1N1 2009 virus and HI cross-reactivity with contemporary swine influenza virus antisera. Influenza and Other Respiratory Viruses 4, 53-60
38. VINCENT, A. L., LAGER, K. M., JANKE, B. H., GRAMER, M. R., RICHT, J. A. (2008b) Failure of protection and enhanced pneumonia with a US H1N2 swine influenza virus in pigs vaccinated with an inactivated classical swine H1N1 vaccine. Veterinary Microbiology 126, 310-323 (Pubitemid 350199605)
39. WESLEY, R. D., TANG, M., LAGER, K. M. (2004) Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus. Vaccine 22, 3427-3434 (Pubitemid 39078761)
40. YEWDELL, J. W., BENNINK, J. R., SMITH, G. L., MOSS, B. (1985) Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes. Proceedings of the National Academy of Sciences of the United States of America 82, 1785-1789 (Pubitemid 15085262)
41. ZHONG, W., LIU, F., DONG, L., LU, X., HANCOCK, K., REINHERZ, E. L., KATZ, J. M., SAMBHARA, S. (2010) Significant impact of sequence variations in the nucleoprotein on CD8 T cell-mediated cross-protection against influenza A virus infections. PLoS ONE 5, e10583
42. ZUCKERMANN, F. A. (1999) Extrathymic CD4/CD8 double positive T cells. Veterinary Immunology and Immunopathology 72, 55-66
43. ZUCKERMANN, F. A., HUSMANN, R. J., SCHWARTZ, R., BRANDT, J., MATEU DE ANTONIO, E., MARTIN, S. (1998) Interleukin-12 enhances the virus-specific interferon gamma response of pigs to an inactivated pseudorabies virus vaccine. Veterinary Immunology and Immunopathology 63, 57-67 (Pubitemid 28288330)